Femme et Homme
- | Pays :
- Mexico
- Canada
- Italy
- Les 3 autres...
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of this study is to compare the efficacy and safety of 3 dose levels of oral ERB-041 administered daily for 12 weeks versus placebo in subjects with active rheumatoid arthritis who have had a suboptimal response to therapy with stable doses of methotrexate (MTX).
Critère d'inclusion
- Rheumatoid Arthritis